Your browser doesn't support javascript.
loading
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
Zlotta, Alexandre R; Ballas, Leslie K; Niemierko, Andrzej; Lajkosz, Katherine; Kuk, Cynthia; Miranda, Gus; Drumm, Michael; Mari, Andrea; Thio, Ethan; Fleshner, Neil E; Kulkarni, Girish S; Jewett, Michael A S; Bristow, Robert G; Catton, Charles; Berlin, Alejandro; Sridhar, Srikala S; Schuckman, Anne; Feldman, Adam S; Wszolek, Matthew; Dahl, Douglas M; Lee, Richard J; Saylor, Philip J; Michaelson, M Dror; Miyamoto, David T; Zietman, Anthony; Shipley, William; Chung, Peter; Daneshmand, Siamak; Efstathiou, Jason A.
Affiliation
  • Zlotta AR; Divisions of Urology and Surgical Oncology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, University of Toronto, Toronto, ON, Canada; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada. Electron
  • Ballas LK; Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Niemierko A; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Lajkosz K; Department of Biostatistics, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Kuk C; Divisions of Urology and Surgical Oncology, Department of Surgery, Mount Sinai Hospital, Sinai Health System, University of Toronto, Toronto, ON, Canada; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Miranda G; Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Drumm M; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
  • Thio E; Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Fleshner NE; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Kulkarni GS; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Jewett MAS; Divisions of Urology and Surgical Oncology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Bristow RG; Manchester Cancer Research Centre and University of Manchester, Manchester, UK.
  • Catton C; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Berlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Sridhar SS; Department of Medical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Schuckman A; Aresty Department of Urology, Kenneth Norris Jr Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Feldman AS; Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wszolek M; Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Dahl DM; Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Lee RJ; MGH Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Saylor PJ; MGH Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Michaelson MD; MGH Cancer Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Miyamoto DT; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zietman A; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Shipley W; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Chung P; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Daneshmand S; Aresty Department of Urology, Kenneth Norris Jr Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Lancet Oncol ; 24(6): 669-681, 2023 06.
Article in En | MEDLINE | ID: mdl-37187202
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article